Hye Gyeong Shin

Title: Hye Gyeong Shin: Innovator in Pharmaceutical Composition

Introduction

Hye Gyeong Shin is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release formulations. His innovative work aims to enhance patient treatment efficiency while minimizing side effects.

Latest Patents

Hye Gyeong Shin holds a patent for a rivastigmine-containing sustained-release pharmaceutical composition. This invention focuses on a preparation that includes a pH-dependent delayed release phase. By controlling the release of the pharmaceutical composition to be minimized in the stomach during the initial stage of administration, it effectively lowers the maximum blood concentration (Cmax) compared to existing products. This approach allows for the maintenance of an effective blood concentration through sustained release, ultimately enabling once-a-day dosing instead of the traditional twice-a-day regimen.

Career Highlights

Hye Gyeong Shin is associated with Navipharm Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His research and development efforts are aimed at improving the convenience of administration for patients, thereby increasing treatment efficiency.

Collaborations

He collaborates with talented coworkers, including Sang Geun Park and Jeong Woo Bae, who contribute to the advancement of their projects and innovations.

Conclusion

Hye Gyeong Shin's work in developing a rivastigmine-containing sustained-release pharmaceutical composition exemplifies his commitment to enhancing patient care through innovation. His contributions to the pharmaceutical industry are noteworthy and reflect a dedication to improving treatment methodologies.